Literature DB >> 989540

Serum levels of immunoglobulin and complement in giant-cell arteritis.

B E Malmvall, B A Bengtsson, B Kaijser, L A Nilsson, K Alestig.   

Abstract

The levels of IgG, total complement, and complement factors C3 and C4 were elevated in serum from patients with giant-cell arteritis as compared to a control group of patients in the same range of age. No increase of the IgM concentration was found. The concentration of IgA was higher in men with giant-cell arteritis as compared to men in a control group. This increase of IgA was not seen in women. There were no statistically significant differences in any of the studied variables between those with a histologically verified arteritis on temporal biopsy specimens and those without.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 989540

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


  10 in total

1.  Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  B Dasgupta; O Duke; A M Timms; C Pitzalis; G S Panayi
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

2.  Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  A J Smith; V Kyle; T E Cawston; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

Review 3.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study.

Authors:  B Dasgupta; O Duke; V Kyle; D G Macfarlane; B L Hazleman; G S Panayi
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

5.  T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis.

Authors:  R Andersson; R Jonsson; A Tarkowski; B A Bengtsson; B E Malmvall
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

6.  Acute hearing loss in giant cell arteritis.

Authors:  D A Francis; H G Boddie
Journal:  Postgrad Med J       Date:  1982-06       Impact factor: 2.401

7.  [Facial edema as an earlier presenting sign of giant cell arteritis. Possible relationship with angioedema].

Authors:  G Bahat; S Akin; F Tufan; A Gelincik; N Erten; M A Karan
Journal:  Z Rheumatol       Date:  2011-02       Impact factor: 1.372

8.  Hypocomplementemia during tocilizumab treatment: Long-term follow-up results.

Authors:  Amir Bieber; Doron Markovits; Kohava Toledano; Yonit Tavor; Reuven Mader; Alexandra Balbir-Gurman; Yolanda Braun-Moscovici
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

9.  Immune complexes, rheumatoid factors, and cellular immunological parameters in patients with giant cell arteritis.

Authors:  B E Malmvall; B A Bengtsson; L A Nilsson; L M Bjursten
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

Review 10.  Controversies regarding giant cell (temporal, cranial) arteritis.

Authors:  J Eshaghian
Journal:  Doc Ophthalmol       Date:  1979-09-17       Impact factor: 2.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.